Your browser is no longer supported. Please, upgrade your browser.
Settings
PHAT [NASD]
Phathom Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-4.69 Insider Own3.00% Shs Outstand36.30M Perf Week0.73%
Market Cap1.09B Forward P/E- EPS next Y-3.83 Insider Trans-57.20% Shs Float26.48M Perf Month1.62%
Income-143.80M PEG- EPS next Q-1.07 Inst Own79.10% Short Float3.77% Perf Quarter-22.90%
Sales- P/S- EPS this Y62.40% Inst Trans-0.16% Short Ratio10.14 Perf Half Y-26.60%
Book/sh4.53 P/B7.62 EPS next Y6.60% ROA-56.10% Target Price58.17 Perf Year-30.14%
Cash/sh7.55 P/C4.57 EPS next 5Y- ROE-81.80% 52W Range28.10 - 50.78 Perf YTD3.97%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-34.55% Beta-
Dividend %- Quick Ratio5.90 Sales past 5Y- Gross Margin- 52W Low18.27% ATR2.04
Employees55 Current Ratio5.90 Sales Q/Q- Oper. Margin- RSI (14)41.00 Volatility4.21% 6.25%
OptionableYes Debt/Eq0.29 EPS Q/Q-19.90% Profit Margin- Rel Volume0.46 Prev Close34.54
ShortableYes LT Debt/Eq0.22 EarningsMar 30 AMC Payout- Avg Volume98.53K Price33.24
Recom1.90 SMA20-4.34% SMA50-7.96% SMA200-15.25% Volume31,399 Change-3.78%
May-12-21Upgrade Goldman Sell → Neutral $40 → $48
Feb-17-21Initiated BMO Capital Markets Outperform $63
Feb-02-21Initiated Guggenheim Buy $60
Jun-26-20Downgrade Goldman Neutral → Sell $34
Nov-20-19Initiated Evercore ISI Outperform
Nov-19-19Initiated Needham Buy $40
Nov-19-19Initiated Jefferies Buy $32
Nov-19-19Initiated Goldman Neutral $32
May-25-21 04:01PM  
May-11-21 08:00AM  
May-06-21 05:48PM  
Apr-29-21 04:01PM  
Apr-06-21 08:00AM  
Mar-30-21 04:05PM  
Feb-17-21 10:12AM  
Feb-02-21 10:07AM  
Jan-19-21 08:30AM  
Dec-16-20 06:43PM  
Dec-15-20 04:01PM  
Dec-14-20 08:30AM  
Dec-08-20 09:00AM  
Dec-02-20 11:33PM  
Nov-30-20 04:05PM  
Nov-27-20 08:00AM  
Nov-19-20 04:05PM  
Nov-13-20 04:05PM  
Nov-10-20 04:05PM  
Nov-04-20 04:05PM  
Sep-09-20 08:30AM  
Aug-06-20 08:30AM  
Jul-13-20 08:30AM  
Jun-15-20 08:30AM  
Jun-12-20 10:25PM  
May-28-20 04:30PM  
May-12-20 08:30AM  
Apr-09-20 04:30PM  
Mar-19-20 08:30AM  
Feb-25-20 04:35PM  
Jan-16-20 09:00AM  
Jan-06-20 08:30AM  
Dec-23-19 08:30AM  
Dec-02-19 08:30AM  
08:30AM  
Nov-26-19 08:30AM  
08:30AM  
Nov-25-19 08:30AM  
08:30AM  
Nov-13-19 04:05PM  
Oct-29-19 04:05PM  
Oct-25-19 05:10PM  
Oct-24-19 08:25PM  
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TAKEDA PHARMACEUTICAL CO LTD10% OwnerJun 10Sale35.142,10273,864938,712Jun 11 06:09 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerJun 09Sale35.281,19142,018940,814Jun 11 06:09 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerJun 08Sale35.001003,500942,005Jun 09 06:41 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerJun 07Sale35.052,26479,353942,105Jun 09 06:41 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerJun 02Sale35.184,300151,274944,369Jun 04 06:23 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerJun 01Sale35.7811,211401,130948,669Jun 02 06:08 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 28Sale36.198,905322,305959,880Jun 02 06:08 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 27Sale37.148,453313,953968,785May 28 06:11 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 26Sale36.6412,358452,747977,238May 28 06:11 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 25Sale36.1810,947396,079989,596May 26 09:42 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 24Sale35.6610,594377,8101,000,543May 26 09:42 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 21Sale35.7411,648416,3001,011,137May 24 06:24 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 20Sale35.107,098249,1401,022,785May 24 06:24 AM
Socks David ADirectorMay 20Sale34.663,482120,6871,300,945May 21 06:13 PM
Socks David ADirectorMay 19Sale32.4436,5181,184,8191,304,427May 21 06:13 PM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 14Sale35.001003,5001,029,883May 18 06:02 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 13Sale35.331003,5331,029,983May 14 06:04 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 12Sale35.4411,776417,3591,030,083May 14 06:04 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 07Sale35.031,01135,4151,041,859May 11 06:30 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 06Sale35.012027,0721,042,870May 07 07:22 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 05Sale35.146,936243,7311,043,072May 07 07:22 AM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 04Sale36.0419,360697,8081,050,008May 05 08:26 AM
Nabulsi AzmiChief Operating OfficerMay 04Sale36.864,457164,302765,700May 04 08:31 PM
TAKEDA PHARMACEUTICAL CO LTD10% OwnerMay 03Sale38.2814,632560,0411,069,368May 05 08:26 AM
Nabulsi AzmiChief Operating OfficerMay 03Sale38.2710,043384,354770,157May 04 08:31 PM
Socks David ADirectorApr 06Sale37.1717,882664,6841,340,945Apr 07 04:13 PM
Nabulsi AzmiChief Operating OfficerApr 05Sale36.119,353337,733780,200Apr 05 07:01 PM
Socks David ADirectorApr 05Sale36.0522,118797,4051,358,827Apr 07 04:13 PM
Nabulsi AzmiChief Operating OfficerApr 01Sale37.575,147193,369789,553Apr 05 07:01 PM
Curran TerriePresident and Chief ExecutiveMar 22Option Exercise6.9511,51380,01511,513Mar 23 07:22 PM
Curran TerriePresident and Chief ExecutiveMar 22Sale43.3211,513498,7510Mar 23 07:22 PM
Socks David ADirectorMar 12Sale46.6750023,3351,380,945Mar 12 05:54 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerMar 11Sale43.75710,00031,062,5003,115,008Mar 15 04:36 PM
Socks David ADirectorMar 11Sale47.1942,4292,002,0981,381,445Mar 12 05:54 PM
Socks David ADirectorMar 10Sale49.0112,071591,6571,423,874Mar 12 05:54 PM
Nabulsi AzmiChief Operating OfficerMar 02Sale45.909,127418,928794,700Mar 03 08:20 PM
Nabulsi AzmiChief Operating OfficerMar 01Sale45.855,373246,362803,827Mar 03 08:20 PM
Socks David ADirectorFeb 23Sale43.744,984217,9911,435,945Feb 23 06:14 PM
Socks David ADirectorFeb 22Sale45.6620,140919,5871,440,929Feb 23 06:14 PM
Socks David ADirectorFeb 19Sale47.1844,8762,117,0341,461,069Feb 23 06:14 PM
Nabulsi AzmiChief Operating OfficerFeb 02Sale40.979,084372,156809,200Feb 03 04:05 PM
Nabulsi AzmiChief Operating OfficerFeb 01Sale38.095,416206,285818,284Feb 03 04:05 PM
Socks David ADirectorJan 12Sale36.0727,165979,7951,532,945Jan 13 05:07 PM
Socks David ADirectorJan 11Sale34.9212,835448,2431,560,110Jan 13 05:07 PM
Socks David ADirectorDec 17Sale40.7448,2121,964,3761,572,945Dec 18 08:01 PM
Socks David ADirectorDec 16Sale47.5331,4461,494,5191,621,157Dec 18 08:01 PM
Nabulsi AzmiChief Operating OfficerDec 02Sale45.267,302330,512838,200Dec 03 06:01 PM
Nabulsi AzmiChief Operating OfficerDec 01Sale44.207,198318,176845,502Dec 03 06:01 PM
Socks David ADirectorNov 11Sale38.976,877268,0211,652,603Nov 12 04:13 PM
Socks David ADirectorNov 10Sale41.6912,681528,6721,659,480Nov 12 04:13 PM
Socks David ADirectorNov 09Sale42.3310,784456,5061,676,562Nov 12 04:13 PM
Nabulsi AzmiChief Operating OfficerNov 02Sale36.8314,500534,026852,700Nov 03 06:40 PM